Eighty-six
Thy1-GFP+ Sprague Dawley (SD) rats (250–300 g) were used for the development of an animal model of NK and corneal neurotization in the rat. The
Thy1-GFP+ rat expresses green fluorescent protein in axons,
27 which permits the visualization of the native corneal innervation, as shown in
Supplementary Figure S1, and reinnervation of the cornea with corneal neurotization after corneal denervation. Establishing a model of NK and corneal neurotization included determining the correct stereotactic coordinates and the appropriate settings for electrocautery ablation of the ophthalmomaxillary nerve, as well as the length of time required for corneal reinnervation from the donor nerve. An additional 24
Thy1-GFP+ Sprague Dawley rats (250–300 g) were used for the validation of the NK model, and 42 Sprague Dawley rats (250–300 g) were used to examine corneal epithelial maintenance and healing after injury.
All rats were maintained in a temperature- and humidity-controlled environment with a 12:12 hour light:dark cycle and received ad libitum water and standard rat chow (Purina, Mississauga, ON, Canada). Surgical procedures were conducted in an aseptic manner with an operating microscope (Leitz, Willowdale, ON, Canada) under inhalational anesthetic (2% isoflurane in 98% oxygen; Halocarbon Laboratories, River Edge, NJ, USA). Rats were provided with buprenorphine (1 mg/kg; Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA) for pain relief after all surgical procedures. Rats were euthanized at study termination under deep anesthesia by using intraperitoneal Euthanyl (sodium pentobarbital, 240 mg/mL concentration, 1 mL/kg; Bimeda-MTC, Cambridge, ON, Canada). Experiments were approved by The Hospital for Sick Children Laboratory Animal Services, which adheres to the guidelines of the Canadian Council on Animal Care. All procedures adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.